Direct enhancement of GABA-ergic neurotransmission by ammonia

Advances in Experimental Medicine and Biology

Volumn 420, Issue , 1997, Pages 85-94

  Ha, Jeoung Hee ^a,b   Knauer, Scott ^a,c   Moody, Eric ^a,c   Jones, E Anthony ^d   Basile, Anthony S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Yeungnam University College of Medicine   (South Korea)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; AMMONIA; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; CHLORIDE; FLUNITRAZEPAM; MUSCIMOL;

CENTRAL NERVOUS SYSTEM DEPRESSION; CHLORIDE CURRENT; CONFERENCE PAPER; ELECTROPHYSIOLOGY; HEPATIC ENCEPHALOPATHY; INHIBITORY POSTSYNAPTIC POTENTIAL; LIGAND BINDING; LIVER FAILURE; NEUROTRANSMISSION; PRIORITY JOURNAL;

EID: 0030805380     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5945-0_6     Document Type: Conference Paper

References (23)

1. G. Gabuzda, G.B Phillips, and C.S. Davidson, Reversible toxic manifestations in patients with cirrhsis of the liver given cation-exchange resins, New Engl. J. Med. 246:124 (1952).
2. H.D. Lux, E. Loracher, and E. Neher, The action of ammonium on postsynaptic inhibition of cat spinal motoneurons, Exp. Brain Res., 11:431 (1970).
3. W. Raabe and R.J. Gumnit, Disinhibition in cat motor cortex by ammonia, J. Neurophysiol. 38:347 (1975).
4. H.D. Lux, Ammonium and chloride extrusion: Hyperpolarizing synaptic inhibition in spinal motoneurons, Science 173:555 (1971).
5. B. E. Alger and R.A. Nicoll, Ammonia does not selectively block IPSPs in rat hippocampal pyramidal cells, J. Neurophysiol. 49:1381 (1983).
6. J.F. Iles and J.J.B. Jack, Ammonia: assessment of its action on postsynaptic inhibition as a cause of convulsions, Brain 103:555 (1983).
7. D.B. Flannery, Y.E. Hsia, and B. Wolf, Current status of hyperammonemia syndromes, Hepatol. 2: 495 (1982).
8. F. Vergara, F. Plum, and T.E. Duffy, α-Ketoglutaramate: increased concentrations in the cerebrospinal fluid of patients in hepatic coma, Science 183:81 (1974).
9. A response in dissociated rat cortical neurons, Neurosci. Lett. 151:51 (1993).
10. A receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes, Brain Res. 720:35 (1996).
11. P. Skolnick, V. Moncada, and J.L. Barker, Pentobarbital: dual actions to increase brain benzodiazepine receptor affinity, Science 211:1448 (1981).
12. F. Leeb-Lundberg, A. Snowman, and R.W. Olsen, Barbiturate receptor sites are coupled to benzodiazepine receptors, Proc. Natl. Acad. Sci. 77:7568 (1980).
13. A receptor by depressant barbiturates and pregnane steroids, Br. J. Pharmacol. 94:1257 (1988).
14. R.W. Olsen and A.M. Snowman, Chloride-dependent enhancement by barbiturates of γ-aminobutyric acid receptor binding, J. Neurosci. 12:1812 (1982).
15. 3H]muscimol binding in rat cerebellar and cerebral cortical membranes by picrotoxin, pentobarbitone, and etomidate, J. Neurochem. 41:418 (1983).
16. A receptors, FASEB J. 4:1469 (1990).
17. M. Willow and G.A.R. Johnston, Dual action of pentobarbitone on GABA binding: role of binding site integrity. J. Neurochem. 37:1291 (1981).
18. B.D. Harris, G. Wong, E.J. Moody, and P. Skolnick, Different subunit requirements for volatile and nonvolatile anesthetics at γ-aminobutyric acid type A receptors, Mol. Pharmacol. 47:363 (1995).
19. A receptor subunits: functional expression and gene localization, in: GABA and Benzodiazepine Receptor Subtypes, G. Biggio and E. Costa, eds., Raven Press, New York, (1990).
20. N. Akaike, K. Hattori, N. Inomata, and Y. Oomura, γ-Aminobutyric and pentobarbitone-gated chloride currents in internally perfused frog sensory neurons, J. Physiol. 360:367 (1985).
21. P. Skolnick, K.C. Rice, J.L. Barker, and S.M. Paul, Interaction of barbiturates with benzodiazepine receptors in the central nervous system, Brain Res. 233:143 (1982
22. A.S. Basile, E.A. Jones, and P. Skolnick, The pathogenesis of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands, Pharmacol. Rev. 43:27 (1991).
23. M.D. Majewska and R.D. Schwartz, Pregnenolone-sulfate: an endogenous antagonist of the γ-aminobutyric acid receptor complex in brain? Brain Res. 404:355 (1987).